Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

WT-161

🥰Excellent
Catalog No. T7385Cas No. 1206731-57-8

WT161 is a potent and selective inhibitor of HDAC6 (IC50:0.40 nM).

WT-161

WT-161

🥰Excellent
Purity: 97.09%
Catalog No. T7385Cas No. 1206731-57-8
WT161 is a potent and selective inhibitor of HDAC6 (IC50:0.40 nM).
Pack SizePriceAvailabilityQuantity
1 mg$36In Stock
2 mg$52In Stock
5 mg$81In Stock
10 mg$122In Stock
25 mg$207In Stock
50 mg$309In Stock
100 mg$467In Stock
1 mL x 10 mM (in DMSO)$85In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "WT-161"

Select Batch
Purity:97.09%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
WT161 is a potent and selective inhibitor of HDAC6 (IC50:0.40 nM).
Targets&IC50
HDAC6:0.40 nM
In vitro
Treatment of anti-multiple myeloma (MM) cell lines with WT161 triggers the accumulation of acetylated tubulin and cell death in MM cell lines more potently than tubacin. Additionally, WT161 in combination with BTZ induces synergistic cytotoxicity and overcomes BTZ resistance in vitro[1].
In vivo
WT161 significantly inhibits in vivo MCF7 cell growth, associated with downregulation of ERα, in a murine xenograft model[2].
Animal Research
Female NCr nu/nu mice were subcutaneously (sc) implanted with 17?-estradiol-sustained release pellets (0.18 mg, 60 day release time). Mice were inoculated sc with 5 × 10^6 MCF-7 cells suspended in 30% Matrigel. After 1 month of growth, mice with measurable tumors (> 50 mm^3) were assigned into cohorts receiving intraperitoneal WT161 daily (80 mg/kg) or into a control group receiving vehicle alone (10% DMSO, 90% PBS). Caliper measurements of the longest perpendicular tumor diameters were performed every alternate day to estimate the tumor volume, using the formula volume = ? x L x W^2. Animals were sacrificed when tumors reached 2 cm or if the mice appeared moribund. For each animal, relative tumor volume was determined by normalizing data to the baseline tumor volume for that animal at the start of treatment. Statistical significance was determined by 2-way ANOVA analysis[2].
Chemical Properties
Molecular Weight458.55
FormulaC27H30N4O3
Cas No.1206731-57-8
SmilesN(C1=CC=C(C=NNC(CCCCCCC(NO)=O)=O)C=C1)(C2=CC=CC=C2)C3=CC=CC=C3
Relative Density.1.15 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 100 mg/mL (218.08 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1808 mL10.9039 mL21.8079 mL109.0394 mL
5 mM0.4362 mL2.1808 mL4.3616 mL21.8079 mL
10 mM0.2181 mL1.0904 mL2.1808 mL10.9039 mL
20 mM0.1090 mL0.5452 mL1.0904 mL5.4520 mL
50 mM0.0436 mL0.2181 mL0.4362 mL2.1808 mL
100 mM0.0218 mL0.1090 mL0.2181 mL1.0904 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy WT-161 | purchase WT-161 | WT-161 cost | order WT-161 | WT-161 chemical structure | WT-161 in vivo | WT-161 in vitro | WT-161 formula | WT-161 molecular weight